Nvidia (NVDA) stock is in focus ahead of the artificial intelligence (AI) chipmaker's third quarter earnings report. Goldman ...

The warning comes from a new JPMorgan note that says the company may be removed from major equity indices — including the ...

Meyer Shields of Keefe, Bruyette & Woods recently downgraded Berkshire Hathaway stock to a sell rating. Many of Berkshire's ...

American Healthcare REIT has just filed for a follow-on equity offering of 8.1 million shares. This move comes after renewed optimism from major banks about the company’s growth prospects and ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $48.95, with a ...

Outside the U.S., Goldman Sachs paints a markedly more optimistic picture. European stocks are forecast to return 7.1% per ...

A reasonable compromise within its peer group. Our research team assigns Bronze ratings to strategies they’re confident will outperform a relevant index, or most peers, over a market cycle on a ...

Shares in UK private equity firm 3i slumped on Thursday after the FTSE 100 group revealed slowing growth at discount retailer ...

Solid approach to covered calls still carries long-term costs. Our research team assigns Silver ratings to strategies that they have a high conviction will outperform the relevant index, or most peers ...

Analysts have doubled their price target for Nova Minerals to US$50 per ADS, highlighting growing confidence in the dual-listed company’s ability to unlock value across its Estelle gold and critical ...

President Donald Trump backed the idea of mortgages with 50-year terms, comparing it to Franklin D. Roosevelt's adoption of ...

An update from Dogwood Therapeutics ( ($DWTX) ) is now available. On November 21, 2025, Dogwood Therapeutics, Inc. held a special meeting where ...